Free Trial

ARS Pharmaceuticals (SPRY) Institutional Ownership

→ World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad)
Free SPRY Stock Alerts
$8.09
-0.17 (-2.06%)
(As of 04/25/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for ARS Pharmaceuticals (NASDAQ:SPRY)

Current
Institutional Ownership
Percentage
68.16%
Number of
Institutional Buyers
(last 12 months)
29
Total
Institutional Inflows
(last 12 months)
$101.72M
Number of
Institutional Sellers
(last 12 months)
10
Total
Institutional Outflows
(last 12 months)
$32.67M
Get SPRY Insider Trade Alerts

Want to know when executives and insiders are buying or selling ARS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

SPRY Institutional Buying and Selling by Quarter

ARS Pharmaceuticals Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/14/2024Sectoral Asset Management Inc.354,641$1.94M0.8%-66.2%0.369%
2/13/2024Tower Research Capital LLC TRC 7,065$39K0.0%-80.2%0.007%
2/9/2024Franklin Resources Inc.4,098,497$22.46M0.0%+5.9%4.269%
2/6/2024AJOVista LLC7,822$43K0.1%N/A0.008%
2/6/2024Levin Capital Strategies L.P.52,250$286K0.0%-61.0%0.054%
2/6/2024Swiss National Bank66,000$362K0.0%-19.8%0.069%
1/25/2024Nisa Investment Advisors LLC5,600$31K0.0%+22,300.0%0.006%
1/24/2024China Universal Asset Management Co. Ltd.11,105$61K0.0%+352.7%0.012%
1/19/2024 Denali Advisors LLC87,500$480K0.1%N/A0.091%
1/10/2024 Charles Schwab Trust Co3,996,071$21.90M2.2%-5.9%4.163%
11/15/2023Tejara Capital Ltd103,739$392K0.2%-22.3%0.108%
11/15/2023RA Capital Management L.P.9,459,678$35.76M0.7%+214.3%9.854%
11/15/2023Sectoral Asset Management Inc.1,049,191$3.97M0.8%-16.4%1.093%
11/14/2023Rubric Capital Management LP639,203$2.42M0.1%-77.2%0.666%
11/13/2023FMR LLC1,307,340$4.94M0.0%-72.0%1.362%
11/13/2023Tejara Capital Ltd103,739$392K0.3%-22.3%0.108%
11/9/2023Letko Brosseau & Associates Inc.36,000$136K0.0%N/A0.038%
11/8/2023Janney Montgomery Scott LLC24,072$91K0.0%-39.8%0.025%
10/24/2023Bank of New York Mellon Corp83,924$317K0.0%+9.1%0.088%
10/23/2023FAS Wealth Partners Inc.45,970$174K0.0%+34.2%0.048%
10/20/2023 Charles Schwab Trust Co4,246,071$16.05M1.8%N/A4.443%
10/12/2023Brendel Financial Advisors LLC19,125$72K0.1%N/A0.020%
10/11/2023Vontobel Holding Ltd.260,684$985K0.0%-24.2%0.273%
9/21/2023Barclays PLC20,460$138K0.0%N/A0.021%
8/14/2023Caption Management LLC73,400$492K0.0%N/A0.077%
8/11/2023Sectoral Asset Management Inc.1,255,640$8.41M1.4%N/A1.325%
8/11/2023Rubric Capital Management LP2,799,203$18.76M0.8%-19.6%2.954%
8/11/2023Tejara Capital Ltd133,521$895K0.4%N/A0.141%
8/10/2023Nicholas Investment Partners LP275,000$1.84M0.1%N/A0.290%
8/8/2023FAS Wealth Partners Inc.34,250$229K0.0%N/A0.036%
8/7/2023Royce & Associates LP463,700$3.11M0.0%+52.6%0.489%
8/4/2023American International Group Inc.11,672$78K0.0%N/A0.012%
8/1/2023Arizona State Retirement System10,606$71K0.0%N/A0.011%
7/31/2023Levin Capital Strategies L.P.169,074$1.13M0.1%N/A0.178%
7/28/2023Shell Asset Management Co.65,322$438K0.0%N/A0.069%
7/26/2023Janney Montgomery Scott LLC39,969$268K0.0%N/A0.042%
7/25/2023DekaBank Deutsche Girozentrale35,000$231K0.0%N/A0.037%
7/24/2023Vontobel Holding Ltd.344,029$2.31M0.0%N/A0.363%
7/19/2023Teacher Retirement System of Texas10,244$69K0.0%N/A0.011%
7/18/2023Avantax Planning Partners Inc.32,174$216K0.0%N/A0.034%
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>
6/1/2023Prelude Capital Management LLC15,053$98K0.0%N/A0.016%
5/23/2023Royce & Associates LP303,900$1.98M0.0%N/A0.321%
5/19/2023SR One Capital Management LP4,012,903$26.12M8.9%N/A4.234%
5/16/2023Baker BROS. Advisors LP2,006,451$13.06M0.1%N/A2.121%
(Data available from 1/1/2016 forward)

SPRY Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of SPRY shares?

During the previous two years, 33 institutional investors and hedge funds held shares of ARS Pharmaceuticals. The most heavily invested institutionals were RA Capital Management L.P. ($35.76M), SR One Capital Management LP ($26.12M), Franklin Resources Inc. ($22.46M), Charles Schwab Trust Co ($21.90M), Baker BROS. Advisors LP ($13.06M), FMR LLC ($4.94M), and Royce & Associates LP ($3.11M).Learn more on SPRY's institutional investors.

What percentage of ARS Pharmaceuticals stock is owned by institutional investors?

68.16% of ARS Pharmaceuticals stock is owned by institutional investors. Learn more on SPRY's institutional investor holdings.

Which institutional investors have been buying ARS Pharmaceuticals stock?

Of the 29 institutional investors that purchased ARS Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($6.45M), Charles Schwab Trust Co ($4.25M), SR One Capital Management LP ($4.01M), Baker BROS. Advisors LP ($2.01M), Sectoral Asset Management Inc. ($1.26M), Royce & Associates LP ($463.70K), and Vontobel Holding Ltd. ($344.03K).

How much institutional buying is happening at ARS Pharmaceuticals?

Institutional investors have bought a total of 20,117,945 shares in the last 24 months. This purchase volume represents approximately $101.72M in transactions.

Which ARS Pharmaceuticals major shareholders have been selling company stock?

Of the 10 institutional investors that sold ARS Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($3.36M), Rubric Capital Management LP ($2.84M), Sectoral Asset Management Inc. ($901.00K), Charles Schwab Trust Co ($250K), Vontobel Holding Ltd. ($83.35K), Levin Capital Strategies L.P. ($81.75K), and Tejara Capital Ltd ($59.56K).

How much institutional selling is happening at ARS Pharmaceuticals?

Institutional investors have sold a total of 7,635,383 shares in the last 24 months. This volume of shares sold represents approximately $32.67M in transactions.


Related Companies:
This page (NASDAQ:SPRY) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
These AI trades triggered this morning (545% return)
Prosper Trading Academy
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
He Is Giving Away Bitcoin
Crypto Swap Profits
Jim Cramer’s “The Biggest Drug Ever”
Behind the Markets
Your Money is Not Safe
American Alternative
The AI stock to buy right now
StockEarnings
The only accurate crypto trading system I know …
Weiss Ratings